Table 2.
Details of comparison between diode laser and sclerotherapy.
| Laser group | STS group | Chi sq- | P-value | |
|---|---|---|---|---|
| Details of site of involvement | ||||
| Gingiva | 19(44.2%) | 13 (43.3%) | 2.833 | 0.844 NS |
| Tongue | 8 (18.6%) | 7 (23.3%) | ||
| Buccal mucosa | 3 (7%) | 2 (6.7%) | ||
| Upper lip | 3 (7%) | 3 (10%) | ||
| Lower lip | 2 (4.7%) | 2 (6.7%) | ||
| Lower labial mucosa | 2 (4.7%) | 1 (3.3%) | ||
| Upper labial mucosa | 1 (2.3%) | 1 (3.3%) | ||
| Palate | 3 (7%) | 0 | ||
| Retrocommissural area | 2 (4.7%) | 1 (3.3%) | ||
| Total | 43 (100%) | 30 (100%) | ||
|
| ||||
| Details of size of involvement | ||||
| Less than 1.5 cm | 22 (51.1%) | 11 (36.6%) | 1.825 | 0.401 NS |
| 1.6-2.0 cm | 18 (41.8%) | 15 (50%) | ||
| More than 2.0 cm | 3 (7.1%) | 4 (13.4) | ||
| Total | 43 (100%) | 30 (100%) | ||
|
| ||||
| Details of the number of session | ||||
| 1 session | 35 (81.3%) | 05 (16.6%) | 29.89 | <0.001 ∗∗ |
| More than 1 session | 08 (18.6%) | 25 (83.4%) | ||
| Total | 43 (100%) | 30 (100%) | ||
|
| ||||
| Details of the side effects | ||||
| Bleeding | 27 (62.8%) (minor bleeding) | 17 (56.7%) (minor bleeding) | 0.277 | 0.599 NS |
| Pain | 33 (76.7%) | 30 (100%) | 8.084 | 0.004 ∗ |
| Edema | 04 (9.3%) | 10 (13.3%) | 6.584 | 0.010 ∗ |
| Superficial ulceration | 00 | 30 (100%) | 73 | <0.001 ∗∗ |
| Ecchymosis/necrosis | 00 | 02(6.7%) | 2.947 | 0.086 NS |
| Infection | 00 | 02 (6.7%) | 2.947 | 0.086 NS |
| Scarring | 05 (11.6%) | 02 (6.7%) | 7.694 | 0.006 ∗ |
|
| ||||
| Details of the VAS scale on the 3rd day of treatment | ||||
| 7-10 VAS | 00 | 22 (7.37%) | 51.447 | <0.001 ∗∗ |
| 4-6 VAS | 15 (34.9%) | 08 (26.7%) | ||
| 1-3 VAS | 23 (53.5%) | 00 | ||
| 0 VAS/no pain | 05 (11.6%) | 00 | ||
| Total | 43 (100%) | 30 (100%) | ||
|
| ||||
| Response of treatment to individual groups | ||||
| Complete response | 43 (100%) | 27 (90%) | 4.484 | 0.034 ∗ |
| Moderate response | 00 | 00 | ||
| No response | 00 | 03 | ||
| Total | 43 (100%) | 30 (100%) | ||
|
| ||||
| Time required for complete resolution/healing | ||||
| 1 week | 08 (18.6%) | 00 | 27.378 | <0.001 ∗∗ |
| 2 weeks | 23 (53.5%) | 04 (13.3%) | ||
| 3 weeks | 12 (27.9%) | 21 (7.5) | ||
| More than 3 weeks | 00 | 05 (16.7%) | ||
| Total | 43 (100%) | 30 (100%) | ||
|
| ||||
| Details of the recurrences based on site | ||||
| Recurrences | 04 (9.3%) | 00 | 2.322 | 0.067 NS |
| No recurrence | 39 (90.7%) | 30 (100%) | ||
| Total | 43 (100%) | 30 (100%) | ||